Skip to Content

Molecular Pharmacology USA Ltd MLPH

Morningstar Rating
$0.00 0.00 (99.67%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MLPH is trading at a 65% discount.
Price
$0.00
Fair Value
$6.12
Uncertainty
Extreme
1-Star Price
$1.59
5-Star Price
$5.55
Economic Moat
Jhpx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MLPH is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.00 / $0.03
Market Cap
$111.55
Volume/Avg
40,000 / 71,908

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Molecular Pharmacology USA Ltd is a development stage enterprise, as defined in Accounting Standards Codification Development Stage Entities. The Company is devoting all of its present efforts to securing and establishing a new business and its current planned principle operations have not commenced. Accordingly, no revenue has been derived during the organization period. The Company was in the business of mineral exploration and development of a mineral property.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees
Website

Valuation

Metric
MLPH
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
MLPH
Quick Ratio
0.00
Current Ratio
0.00
Interest Coverage
Quick Ratio
MLPH

Profitability

Metric
MLPH
Return on Assets (Normalized)
−1,128.43%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
MLPH
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRRhjj$531.9 Bil
VRTX
Vertex Pharmaceuticals IncWjqcb$108.7 Bil
REGN
Regeneron Pharmaceuticals IncKttfm$106.0 Bil
MRNA
Moderna IncRdr$35.2 Bil
ARGX
argenx SE ADRJsylr$22.1 Bil
BNTX
BioNTech SE ADRVrblb$21.1 Bil
ALNY
Alnylam Pharmaceuticals IncBbrhdx$19.0 Bil
BMRN
Biomarin Pharmaceutical IncQfppych$16.3 Bil
RPRX
Royalty Pharma PLC Class ACbpybz$13.6 Bil
INCY
Incyte CorpHzwhfks$13.1 Bil

Sponsor Center